|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06660 AIM VACCINE
Nominal 
4.650 -0.170 (-3.527%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 514,657 | -4.192% | 1,285,031 | 1,187,468 | 1,264,073 | 1,570,129 |
| Cost of Sales | (173,421) | 16.477% | (331,523) | (286,452) | (236,414) | (275,429) |
| Gross Profit | 341,236 | -12.118% | 953,508 | 901,016 | 1,027,659 | 1,294,700 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | (32,746) | (61,091) | -- | -- | |
| Change in FV & Impairment on Others | (7,644) | 98.185% | 6,258 | (1,727,854) | (27,215) | (7,981) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (151,657) | -4.804% | (290,718) | (2,270,645) | (434,165) | (606,703) | |
| Taxation | 15,663 | 11.512% | 12,249 | 320,404 | 203,535 | (69,170) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 4,878 | -18.835% | 1,235 | 649,236 | (88,971) | (16,901) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (131,116) | -5.844% | (277,234) | (1,301,005) | (319,601) | (692,774) | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 26,151 | 1.985% | 53,305 | 33,125 | 14,999 | (74) |
| Depreciation & Amortisation | 81,524 | -11.658% | 172,029 | 174,697 | 166,441 | 144,291 |
| Directors' Emoluments | -- | -- | 9,606 | 8,035 | 78,463 | 902,616 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -11.000 | 0.000% | -23.000 | -107.000 | -27.000 | -60.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.082 | (0.137) | (0.092) | 0.080 |
| NBV per share ($) | 2.693 | -- | 2.779 | 3.008 | 4.096 | -- |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -131,116 |
| %Change | -5.844% |
| EPS / (LPS) | RMB -0.110 |
| NBV Per Share (¥) | RMB 2.693 |